Showing results (161-170 of 1,988) with videos related to

Sort By:
Pageof 199
Annals of Translational Medicine|January 25, 2021
HER2-targeted regimens after prior trastuzumab for patients with HER2-positive unresectable, locally advanced or metastatic breast cancer: a network meta-analysis of randomized controlled trialsXinghui Li, Songwen Wu, Lijie Zhang, et al.
Holistic Integrative Oncology|July 31, 2023
An appropriate treatment interval does not affect the prognosis of patients with breast CancerWei Gao, Jiaxing Wang, Sifei Yin, et al.
Breast Cancer Research and Treatment|July 6, 2018
Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysisJiayu Wang, Binghe Xu, Wenna Wang, et al.
Cancers|December 23, 2022
Endocrine Therapy-Based Strategies for Metastatic Breast Cancer with Different Endocrine Sensitivity Statuses: A Systematic Review and Network Meta-AnalysisJiani Wang, Yiqun Han, Jiayu Wang, et al.
International Journal of Clinical Oncology|January 18, 2022
The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based studyYiqun Han, Yun Wu, Hangcheng Xu, et al.
Breast Cancer Research and Treatment|November 25, 2018
Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysisJiayu Wang, Binghe Xu, Wenna Wang, et al.
Oncology Research and Treatment|August 21, 2022
Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast CancerJiaxuan Liu, Maiyue He, Zijing Wang, et al.
Breast (Edinburgh, Scotland)|April 20, 2010
A retrospective study of metachronous and synchronous ipsilateral supraclavicular lymph node metastases in breast cancer patientsYing Fan, Binghe Xu, Yuqian Liao, et al.
Asia-Pacific Journal of Clinical Oncology|December 1, 2010
A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatmentBinghe Xu, Zhenzhou Shen, Zefei Jiang, et al.
Iscience|June 5, 2023
A phase Ib study of TQB2450 plus anlotinib in patients with advanced triple-negative breast cancerJiayu Wang, Tao Sun, Quchang Ouyang, et al.
Pageof 199